Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 2177 - 2184 of 11616 results
Energy & Sustainability M&A Activity — February 2022
February 2, 2022| Article| Viewpoint
Energy & Sustainability Event Highlights — February 2022
February 2, 2022| Article| Viewpoint
Civil Rights & Voting Rights Acts with Charlie Ferris
February 1, 2022| Video| Viewpoint
The New UK International Data Transfer Agreement Is Ready To Go From March 21, 2022
February 1, 2022| Blog| Viewpoint
Domestic Industry Alive and Well at ITC; Important New Opinion Continues Trend
February 1, 2022| Blog| Viewpoint
Mintz Life Sciences Deal Activity (October – December 2021)
February 1, 2022| Article| Viewpoint
Challenging the Legality of a Cruel Immigration Policy
January 31, 2022| Alert| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.